Ankylosing Spondylitis Plasma

All filters

Format

Format

Format
Sample Attributes

Sample Attributes

Volume
Additive Type
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot (SO) #

Start typing to see matching Lot (SO) #.

SKU

Start typing to see matching SKUs.

Donor ID (PID)

Start typing to see matching Donor ID (PID).

16 lots match
16 lots available Save search Notify me
Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request. Sample TypeBag SizeCells / VolumeAdditive TypePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Ankylosing Spondylitis Plasma 80110 147968 Female 46-60 Caucasian Frozen 1 mL 14 — 5000 Vit D every other week, probiotic, Tylenol PM Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo22.48NoNoNoNoNONoStoredIn Stock
$495 / vial 14 vials left
Ankylosing Spondylitis Plasma 80275 147975 Female 46-60 Caucasian Frozen 1 mL 16 — Cosentyx 150mg/pen injection every 28 days. Percocet 5-325mg twice daily oral. Celebrex 200mg once daily oral. Pristiq 50mg once daily oral. Medication hx: Wellbutrin 150mg QD Embrel history of: Ibuprofen PRN Valtrex 500 mg QD PRN Trintella QD Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisYesGabapentin; Antibiotics;21.92NoNoUsed to Smoke100.25NoNOYesStoredIn Stock
$495 / vial 16 vials left
Ankylosing Spondylitis Plasma 80213 147325 Male 18-30 Caucasian Frozen 1 mL 12 — — Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo23.75NoNoNoNoYESNoStoredIn Stock
$495 / vial 12 vials left
Ankylosing Spondylitis Plasma 80113 147967 Female 31-45 Caucasian Frozen 1 mL 14 — Humira Claritin B QD Gabapentin 100 mg QD Tizanidine 2 mg TID Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLAnkylosing SpondylitisAnkylosing SpondylitisYesNaproxyn; Lactose interolerant22.46NoNoNoNoNONoStoredIn Stock
$495 / vial 14 vials left
Ankylosing Spondylitis Plasma 80107 147178 Male 46-60 Caucasian Frozen 1 mL 13 — Xeljanz - 5mg twice daily - oral Sulfasalazine - 500mg twice daily - oral Pantoprazole - 40mg 1 daily - oral Duloxetine - 30mg 1 daily - oral Celecoxib - 200mg twice daily - oral Tylenol - 500mg as needed - oral Valacyclovir - 1g - as needed - oral Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo32.48NoNoUsed to Smoke101NoNOYesStoredIn Stock
$495 / vial 13 vials left
Ankylosing Spondylitis Plasma 77876 96516 Male 61+ Caucasian Frozen 1 mL 11 — Taltz/80mg/mL/QM Celebrex/200mg/PRN ( has not taken it in long time) Sulfalsalizine QD Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLAnkylosing SpondylitisAnkylosing SpondylitisNo19.37NoNoNoNoNOYesStoredIn Stock
$495 / vial 11 vials left
Ankylosing Spondylitis Plasma 77419 147130 Male 46-60 Caucasian Frozen 1 mL 13 — Duloxetine 60 mg QD Remicade Q8 weeks Methotrexate 7.5 mg QD Folic Acid 1 mg QD Modafinil 100 mg QD Olmesartan 40/25 mg QD Meloxicam 15 mg QD Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo28.89NoNoNoYesNOYesStoredIn Stock
$495 / vial 13 vials left
Ankylosing Spondylitis Plasma 77405 147077 Female 31-45 Hispanic/Latino Frozen 1 mL 16 — None Not taking any medications for hypertension. Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo34.17NoNoNoNoYESYesStoredIn Stock
$495 / vial 16 vials left
Ankylosing Spondylitis Plasma 77504 150438 Female 61+ African American Frozen 1 mL 25 — Gabapentin 100 mg TID Enulose Solution Eye Drops TID Timolol 1 gtt QD Kerendia 10 mg QD Adalimumab Injection Q 2 Weeks Rosuvastatin 20 mg QD Esomeprazole 40 mg QD Estradiol 0.1 mg Vaginal Cream Amlodipine-Olmesartan 20/40 mg QD Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisYesGluten; Silicone; Latex27.44NoNoNoNoNONoStoredIn Stock
$495 / vial 25 vials left
Ankylosing Spondylitis Plasma 76540 147031 Female 46-60 Caucasian Frozen 1 mL 10 — Rosuvastatin 40 MG tablet, metoPROLOL succinate 25 MG 24 hr tablet, losartan 50 MG tablet, ezetimibe 10 MG tablet, fluoxetine 60 MG capsule Voquezna 20 MG Tab gabapentin 100 MG capsule Quetiapine 25 MG tablet Xeljanz XR 11 MG TABLET SR 24 HR Phentermine 37.5 mcg QD Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo29.05NoNoNoYesNOYesStoredIn Stock
$495 / vial 10 vials left
Ankylosing Spondylitis Plasma 72201 136422 Male 61+ Asian/Pacific Islander Frozen 1 mL 15 — Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD Psoriatic Arthritis, Chronic Kidney Disease, Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing Spondylitis;Psoriatic Arthritis;Chronic Kidney DiseaseNo28.79NoNoNoNoNONoStoredIn Stock
$495 / vial 15 vials left
Ankylosing Spondylitis Plasma 71399 145292 Male 61+ Caucasian Frozen 1 mL 8 — Celecoxib 200mg QD Gabapentin 600mg BID Atorvastatin 20mg QD Metoprolol 25mg QD Tamsulosin 0.4mg QD Ankylosing Spondylitis United States 2026 A*01:01:01:01/A*68:02:01:01 — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisNo22.69ReactiveYesNoNoNoNOYesORH+StoredIn Stock
$495 / vial 8 vials left
Ankylosing Spondylitis Plasma 71615 136422 Male 61+ Asian/Pacific Islander Frozen 1 mL 17 — Amitriptyline 100mg QD Sotyktu 6mg QD Atorvastatin 20 mg QD amlodipine 10mg QD Hydrochlorothiazide 25 mg QD Chronic Kidney Disease, Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing Spondylitis;Chronic Kidney DiseaseNo28.79NoNoNoNoNONoStoredIn Stock
$495 / vial 17 vials left
Ankylosing Spondylitis Plasma 71582 147986 Male 46-60 Caucasian Hispanic/Latino Frozen 1 mL 10 — Tramadol 50 mg PRN Ankylosing Spondylitis United States 2026 11:01:01:01/31:01:02:01 — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisYesDust, tree pollens, nuts24ReactiveYesNoUsed to Smoke60.5NoYESYesORH+StoredIn Stock
$495 / vial 10 vials left
Ankylosing Spondylitis Plasma 71484 147056 Male 18-30 Caucasian Frozen 1 mL 6 — Naproxyn 500 mg QD Ankylosing Spondylitis United States 2026 A*30:01:01:01/A*68:01:01:02 — — — — — — — — Plasma1.0 MLEDTAAnkylosing SpondylitisAnkylosing SpondylitisYesSeasonal; Kiwi21.7Non ReactiveYesNoNoYesNOYesORH-StoredIn Stock
$495 / vial 6 vials left
Ankylosing Spondylitis Plasma 68831 147068 Female 61+ Caucasian Frozen 1 mL 14 — Losartin 100 mg Estradiol .5 mg Aldactone 50 mg Levothyroxine 88 mcg Pilocarpine 5 mg 3/day Lexipro 10 mg Nexium 20 mg Gabapentin 400 mg 3/day Buprenorphine/Naloxone 4 mg/1 mg-3/day Atrovent nasal spray .03% 2 Breztri 9 mcg 2/day Albuterol inhaler 90 mcg Vagifem 10 mcg Xiidra 5% dpet Upneeq (PF) 0.1% dpet Cosentyx biologic infusion 109 mg/mo. Gemtesa 75 mg Metropolo tartrate 12.5 mg Acetominophen Ankylosing Spondylitis United States 2026 — — — — — — — — — Plasma1.0 MLAnkylosing SpondylitisAnkylosing SpondylitisYesSulfa Drugs21.3NoNoUsed to Smoke405NoNOYesStoredIn Stock
$495 / vial 14 vials left

Adding a lot to your cart does not reserve it. Lots are confirmed when the order is placed.

Vial counts can change between daily syncs; a ✓ shows when a lot's count was last checked, not a hold.

Showing 1–16 of 16 lots* Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.

About Ankylosing Spondylitis Plasma

Ankylosing Spondylitis Plasma is sourced from consented donors with documented ankylosing spondylitis. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Ankylosing Spondylitis research
  • Immunoassay development
  • Proteomic research
  • Metabolomic research
  • Soluble-protein studies

Product Features

  • Human plasma
  • Donor condition: Ankylosing Spondylitis
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Donor and clinical data in these lots

Fields recorded on the 16 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
16 of 16 lots
Age
16 of 16 lots
Race
16 of 16 lots
BMI
16 of 16 lots

Clinical history

Primary diagnosis
16 of 16 lots
Current medications
15 of 16 lots
Comorbidities (donor-reported)
2 of 16 lots
Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.
Allergies
16 of 16 lots
Infectious disease history
16 of 16 lots

Lab results & genotype

CMV serostatus
3 of 16 lots
ABO / Rh blood type
3 of 16 lots
HLA class I typing
3 of 16 lots

Lifestyle

Tobacco use
16 of 16 lots
Smoking history
4 of 16 lots
Alcohol use
16 of 16 lots
Recreational drug use
16 of 16 lots
Caffeine use
16 of 16 lots

Collection

Collection date
16 of 16 lots
Country of collection
16 of 16 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Shipping terms

Ships frozen on dry ice from the US. International orders welcome.

Domestic

Rates
Shipped frozen on dry ice by overnight courier. $411 per order up to $8,000; $935 above $8,000. Leukopaks: $935 per cryopreserved bag, $550 per fresh bag. Fresh whole blood: $216 per 3 healthy donors or per disease-state donor.
Dispatch
In-stock samples ship in 2 business days.
Own courier account
You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.

International

Rates
$750 per order, shipped on dry ice by a courier designated by Sanguine unless you ask for an alternative.
Title and risk
Title and risk pass to you when the shipment is handed to the carrier (Incoterms 2020 EXW).
Permits, customs and duties
You are responsible for import permits, customs clearance, duties and taxes, and for complying with the export and import laws that apply to you.
Delays
Sanguine is not responsible for delays caused by carriers, customs, or external events.
Own courier account
You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.

More detail on our shipping charges page.

Quality and protocols

  • Plasma Isolation

    Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Plasma

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Ankylosing Spondylitis Plasma with normal donor samples for comparison

Healthy Plasma

208 In Stock
Screened normal donors · Frozen · Starting at $132
View Inventory

Need a custom Plasma cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information